Cortavance (hydrocortisone aceponate) – Conditions or restrictions regarding supply and use - QD07AC

A. MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE

Name and address of the manufacturer of the biological active substance(s)

Hovione Farmaciencia SA

Sete Casas

2674-506 Loures

Portugal

Name and address of the manufacturer(s) responsible for batch release

VIRBAC SA

1ère Avenue - 2065 m – L.I.D

06516 Carros, France

B. CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY OR USE

Veterinary medicinal product subject to prescription.

The holder of this marketing authorisation must inform the European Commission about the marketing plans for the medicinal product authorised by this decision.

C. CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE PRODUCT

Not applicable.

D.STATEMENT OF THE MRLs

Not applicable.

Comments